These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36737419)

  • 1. Combination of echocardiography and pulmonary function tests could predict no complication of pulmonary hypertension during 5 years in patients with systemic sclerosis.
    Yoneda K; Takahashi S; Nakayama K; Iwahashi M; Emoto N; Kumagai S
    Int J Rheum Dis; 2023 Mar; 26(3):493-500. PubMed ID: 36737419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis.
    Colalillo A; Hachulla E; Pellicano C; Smith V; Bergmann C; Riemekasten G; Zanatta E; Henes J; Launay D; Marcoccia A; Gheorghiu AM; Truchetet ME; Iannone F; Simeón Aznar CP; Oliveira S; Vonk M; Del Galdo F; Rosato E;
    Chest; 2024 Oct; 166(4):837-844. PubMed ID: 38849072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.
    Hsu VM; Moreyra AE; Wilson AC; Shinnar M; Shindler DM; Wilson JE; Desai A; Seibold JR
    J Rheumatol; 2008 Mar; 35(3):458-65. PubMed ID: 18203320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests.
    Schreiber BE; Valerio CJ; Keir GJ; Handler C; Wells AU; Denton CP; Coghlan JG
    Arthritis Rheum; 2011 Nov; 63(11):3531-9. PubMed ID: 21769839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis.
    Coghlan JG; Wolf M; Distler O; Denton CP; Doelberg M; Harutyunova S; Marra AM; Benjamin N; Fischer C; Grünig E
    Eur Respir J; 2018 Apr; 51(4):. PubMed ID: 29563168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry.
    Bae S; Saggar R; Bolster MB; Chung L; Csuka ME; Derk C; Domsic R; Fischer A; Frech T; Goldberg A; Hinchcliff M; Hsu V; Hummers L; Schiopu E; Mayes MD; McLaughlin V; Molitor J; Naz N; Furst DE; Maranian P; Steen V; Khanna D
    Ann Rheum Dis; 2012 Aug; 71(8):1335-42. PubMed ID: 22307943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population.
    Hinchcliff M; Fischer A; Schiopu E; Steen VD;
    J Rheumatol; 2011 Oct; 38(10):2172-9. PubMed ID: 21844142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis.
    Ninagawa K; Kato M; Nakamura H; Abe N; Kono M; Fujieda Y; Oku K; Yasuda S; Ohira H; Tsujino I; Atsumi T
    Rheumatol Int; 2019 Nov; 39(11):1883-1887. PubMed ID: 31280357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis.
    Ciurzyński M; Bienias P; Irzyk K; Rymarczyk Z; Kostrubiec M; Szewczyk A; Glińska-Wielochowska M; Zyłkowska J; Kurzyna M; Pruszczyk P
    Kardiol Pol; 2011; 69(1):9-15. PubMed ID: 21267956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multimodal Prediction Model for Diagnosing Pulmonary Hypertension in Systemic Sclerosis.
    Lui JK; Gillmeyer KR; Sangani RA; Smyth RJ; Gopal DM; Trojanowski MA; Bujor AM; Soylemez Wiener R; LaValley MP; Klings ES
    Arthritis Care Res (Hoboken); 2023 Jul; 75(7):1462-1468. PubMed ID: 35678779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension.
    Nagel C; Henn P; Ehlken N; D'Andrea A; Blank N; Bossone E; Böttger A; Fiehn C; Fischer C; Lorenz HM; Stöckl F; Grünig E; Egenlauf B
    Arthritis Res Ther; 2015 Jun; 17(1):165. PubMed ID: 26084934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
    Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR;
    Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.
    Vilela VS; Dias MM; Salgado ÂA; da Silva BRA; Lopes AJ; Bessa EJC; Bruno LP; da Costa CH; Levy RA; Rufino R
    BMC Pulm Med; 2021 Jul; 21(1):251. PubMed ID: 34325685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis.
    Dumitrescu D; Nagel C; Kovacs G; Bollmann T; Halank M; Winkler J; Hellmich M; Grünig E; Olschewski H; Ewert R; Rosenkranz S
    Heart; 2017 May; 103(10):774-782. PubMed ID: 28062514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry.
    Swift AJ; Rajaram S; Hurdman J; Hill C; Davies C; Sproson TW; Morton AC; Capener D; Elliot C; Condliffe R; Wild JM; Kiely DG
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1036-1047. PubMed ID: 23769494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress Doppler echocardiography in systemic sclerosis: evidence for a role in the prediction of pulmonary hypertension.
    Codullo V; Caporali R; Cuomo G; Ghio S; D'Alto M; Fusetti C; Borgogno E; Montecucco C; Valentini G
    Arthritis Rheum; 2013 Sep; 65(9):2403-11. PubMed ID: 23754201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension.
    Valerio CJ; Schreiber BE; Handler CE; Denton CP; Coghlan JG
    Arthritis Rheum; 2013 Apr; 65(4):1074-84. PubMed ID: 23280155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis.
    Denton CP; Cailes JB; Phillips GD; Wells AU; Black CM; Bois RM
    Br J Rheumatol; 1997 Feb; 36(2):239-43. PubMed ID: 9133938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitions and diagnosis of pulmonary hypertension.
    Hoeper MM; Bogaard HJ; Condliffe R; Frantz R; Khanna D; Kurzyna M; Langleben D; Manes A; Satoh T; Torres F; Wilkins MR; Badesch DB
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D42-50. PubMed ID: 24355641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aetiological distribution of pulmonary hypertension and the value of transthoracic echocardiography screening in the respiratory department: A retrospective analysis from China.
    Hong C; Chen R; Hu L; Liu H; Lu J; Zhuang C; Guo W; Wu X; Lin J; Sun X; Tang H; Wang Z; Zhang N; Zheng Z
    Clin Respir J; 2023 Jun; 17(6):536-547. PubMed ID: 37141914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.